- Filed
- Feb 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Feb 14, 2025 | 8.09M sh |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | $20.98M |
| Cash And Equivalents | Q2 2025 · Jun 30, 2024 | $18.29M |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $326.15M |
| Total Liabilities | Q2 2025 · Jun 30, 2024 | $326.97M |
| Total Assets | Q2 2025 · Dec 31, 2024 | $374.21M |
| Total Assets | Q2 2025 · Jun 30, 2024 | $374.97M |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 8.1M sh |
| Shares Diluted | Q2 2025 · Dec 31, 2023 | 8.1M sh |
| Dividends Paid | Q2 2025 · Dec 31, 2023 | $671K |
| Capex | Q2 2025 · Dec 31, 2023 | $45K |
| Operating Cash Flow | Q2 2025 · Dec 31, 2023 | −$1.09M |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $49.18M |
| Stockholders Equity | Q2 2025 · Sep 30, 2023 | $49.65M |
| Stockholders Equity restated | Q2 2025 · Jun 30, 2023 | $50.3M |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | −$0.05 |
| Eps Diluted | Q2 2025 · Dec 31, 2023 | −$0.07 |
| Eps Basic | Q2 2025 · Dec 31, 2023 | −$0.05 |
| Eps Basic | Q2 2025 · Dec 31, 2023 | −$0.07 |
| Net Income | Q2 2025 · Dec 31, 2023 | −$361K |
| Net Income | Q2 2025 · Dec 31, 2023 | −$536K |